Cardiac arrest following injection of concentrated trisodium citrate

Clinical Nephrology

Volumn 69, Issue 4, 2008, Pages 317-318

  Punt, C D ^a   Boer, W E ^a  

^a Zuyderland Medical Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE TRISODIUM; HEPARIN;

AGED; ANTICOAGULATION; BACTERICIDAL ACTIVITY; CASE REPORT; CONTINUOUS HEMOFILTRATION; DIALYSIS CATHETER; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCALCEMIA; LABORATORY TEST; LETTER;

EID: 42049115063     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP69317     Document Type: Letter

References (6)

1. Ash SR, Mankus RA, Sutton JM, Criswell RE, Crull CC, Velasquez KA, Smeltzer BD, Ing TS. Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 2000; 4: 22-31.
2. Charney DI, Salmond R. Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis. ASAIO J 1990; 36: M217-M219.
3. Polaschegg HD, Sodemann K. Risks related to catheter locking solutions containing concentrated citrate. Nephrol Dial Transplant 2003; 18: 2688-2690.
4. Stas KJF, Vanwalleghem J, De Moor B, Keuleers H. Trisodium citrate 30% vs heparin 5% as catheter lock in the interdialytic period in twin-or double-lumen dialysis catheters for intermittent haemodialysis. Nephrol Dial Transplant 2001; 16: 1521-1522.
5. U.S. Food and Drug Administration. FDA Issues Warning on TriCitrasol Dialysis Catheter Anticoagulant. April 14, 2000; FDA Talk Paper T00-16.
6. Weijmer MC, van den Dorpel MA, van de Ven PJG, ter Wee PM, van Geelen JACA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole, CY, Schrander van der Meer AM, Siegert CEH, Stas KJF, for the CITRATE Study Group. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc: Nephrol 2005; 16: 2769-2777.